SCHEMBL13305603

SCHEMBL13305603

COCCNc1ccc(CN(C)c2cc(-c3ccccc3)nc3c(Br)cnn23)cn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 7/20 0.44
▸ GSK3B P49841 3/20 0.42
▸ CHEK1 O14757 1/20 0.41
▸ CCNA2 P20248 1/20 0.41
▸ CCNA1 P78396 1/20 0.41
▸ CCNE1 P24864 5/20 0.41
▸ ALDH1A1 P00352 3/20 0.40
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ POLB P06746 1/20 0.36
▸ SYK P43405 2/20 0.35
▸ HCAR3 P49019 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14545787 0.90 CDK2 (0.45) CDK2GSK3BCHEK1CCNA2CCNA1
SCHEMBL12953175 0.83 CDK2 (0.62) CDK2GSK3BCCNE1
SCHEMBL12953217 0.75 CDK2 (0.62) CDK2GSK3BCCNE1
SCHEMBL13304953 0.73 GSK3B (0.49) CDK2GSK3BCCNE1ALDH1A1MEN1
SCHEMBL12953041 0.70 CDK2 (0.69) CDK2GSK3BCCNE1
SCHEMBL14043147 0.69 GSK3B (0.46) CDK2GSK3BCHEK1CCNA2CCNA1
SCHEMBL12953228 0.68 CDK2 (0.72) CDK2GSK3BCHEK1CCNA2CCNA1
SCHEMBL12953362 0.68 CDK2 (0.68) CDK2GSK3BCCNE1
SCHEMBL12953028 0.68 CDK2 (0.68) CDK2GSK3BCCNE1
SCHEMBL12954112 0.67 CDK2 (0.70) CDK2GSK3BCHEK1CCNA2CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537116-B1 PYRAZOLOPYRIMIDINES SUITABLE FOR THE TREATMENT OF CANCER DISEASES SCHERING CORP (US) 2010-06-02 — — EP disclosed
WO-2007044449-A2 NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2007-04-19 — — WO disclosed
Send feedback